SecBot SecBot
8-K ·Filed Jun 2, 2026

PDSB

PDS Biotechnology Corp
BULLISH
Impact 5/10
Horizondays Processed5mo ago SEC0001140361-26-023698
8-K context-dependent: Items 8.01
Actionable Insight ▲ Bullish

The compliance notice removes a key overhang for PDSB, which had a $64M market cap and 89% analyst bullish consensus. Monitor the stock's ability to sustain above $1.00; any subsequent dip below that threshold could trigger a new 180-day cure period. No financial data or guidance was provided in this filing.

DirectionBullish
Confidencehigh
Horizondays

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.16
T+0 close · Jun 2, 2026 · via day close
Latest settled
−80.76%
T+60 · $0.2232
Vs SPY
−81.88%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 2 $1.16entry
  2. T+1 · 6mo ago −6.90%α −6.20% · $1.08
  3. T+5 · 5mo ago −11.21%α −8.24% · $1.03
  4. T+20 · 5mo ago −24.66%α −23.09% · $0.8740
  5. T+60 · 3mo ago −80.76%α −81.88% · $0.2232
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

PDS Biotechnology Corp received a Nasdaq notice on June 2, 2026 confirming it has regained compliance with the $1.00 minimum bid price requirement, closing the deficiency matter first disclosed on February 25, 2026. This removes the immediate delisting risk from Nasdaq, a positive administrative outcome for the $64M market cap clinical-stage biotech.

Key Facts

  • On February 25, 2026, PDSB received a Nasdaq deficiency letter for trading below $1.00 for 30 consecutive business days.
  • On June 2, 2026, Nasdaq notified PDSB that it has regained compliance with the minimum bid price requirement and closed the matter.
  • The company's common stock continues to trade on The Nasdaq Capital Market under the symbol PDSB.

Financial Impact

No direct financial figures provided; the filing resolves a delisting risk that could have forced a transfer to OTC markets, preserving Nasdaq listing and associated liquidity/premium.

listing statusliquidity

Risk Factors

  • Stock could again fall below $1.00, triggering a new deficiency process.
  • No operational or financial catalysts were disclosed; the compliance notice does not change the company's clinical-stage risk profile.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001140361-26-023698
Document: 0001140361-26-023698-index-headers.html0001140361-26-023698
Document: 0001140361-26-023698.txt0001140361-26-023698

Track record

28 reports on PDSB

Performance horizon

7 of 13 bullish or bearish reports moved the stock their way by T+20. Best: +71.95% at T+20 after the Jul 22, 2026 report. 11 of 13 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $0.8726 Now $0.9240 +5.89% settles Dec 14
  2. Nov 12, 20264d ago SC 13D/A Neutral 4/10 Entry $0.9800 Now $0.9240 −5.71% settles Dec 11
  3. Nov 10, 20266d ago 8-K Neutral 4/10 Entry $1.03 Now $0.9240 −10.29% settles Dec 9
  4. Oct 20, 202627d ago 3 Neutral 2/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  5. Oct 20, 202627d ago 8-K Neutral 4/10 Entry $1.24 Now $0.9240 −25.48% settles Nov 18
  6. Oct 20, 202627d ago 8-K Neutral 3/10 Entry $0.9605 Now $0.9240 −3.80% settles Nov 17
  7. Oct 14, 20264w ago S-3 Bearish 7/10 Entry $1.30 to $0.9800 Now $0.9240 +28.92% ▲ +24.62% +22.71% vs SPY
  8. Oct 6, 20265w ago 8-K Neutral 3/10 Entry $1.05 to $1.41 Now $0.9240 −11.58% ▲ +34.93% +38.10% vs SPY
  9. Sep 22, 20267w ago 8-K Bullish 6/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
  10. Sep 22, 20267w ago Press Release Bullish 7/10 Entry $0.9100 to $0.9605 Now $0.9240 +1.54% ▲ +5.55% +6.11% vs SPY
Showing 10 of 28

US Market Status

Market Closed · Opens in 6h 42m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026